Thursday, July 20, 2017 12:18:08 PM
Debunking phony "facts" about Omni - Omni is profitable and not diluting
More phony "facts" about omni debunked – Omni outperforms most independent pharmacies
Andrey didn't profit from preferred conversions
Omni is undervalued and should be trading at $.05 to $.13 per share
Omni owns Celebcream, its website and exclusive distribution rights – the location of Malecon pharmacy is a competitive advantage
The anti-aging cream market is estimated to be worth $191.7 billion by 2019
Debunked Again
Les
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM